GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Pretax Margin %

U-Neuron Biomedical (ROCO:6973) Pretax Margin % : -191.85% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. U-Neuron Biomedical's Pre-Tax Income for the six months ended in Dec. 2023 was NT$-28.82 Mil. U-Neuron Biomedical's Revenue for the six months ended in Dec. 2023 was NT$15.02 Mil. Therefore, U-Neuron Biomedical's pretax margin for the quarter that ended in Dec. 2023 was -191.85%.

The historical rank and industry rank for U-Neuron Biomedical's Pretax Margin % or its related term are showing as below:

ROCO:6973' s Pretax Margin % Range Over the Past 10 Years
Min: -314.14   Med: -161.15   Max: -39.62
Current: -314.14


ROCO:6973's Pretax Margin % is ranked worse than
58.89% of 1024 companies
in the Biotechnology industry
Industry Median: -152.6 vs ROCO:6973: -314.14

U-Neuron Biomedical Pretax Margin % Historical Data

The historical data trend for U-Neuron Biomedical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Pretax Margin % Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pretax Margin %
- -39.62 -161.15 -314.14

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % - -111.56 -226.65 -467.24 -191.85

Competitive Comparison of U-Neuron Biomedical's Pretax Margin %

For the Biotechnology subindustry, U-Neuron Biomedical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's Pretax Margin % falls into.



U-Neuron Biomedical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

U-Neuron Biomedical's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-84.891/27.023
=-314.14 %

U-Neuron Biomedical's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-28.822/15.023
=-191.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U-Neuron Biomedical  (ROCO:6973) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


U-Neuron Biomedical Pretax Margin % Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines